Eliot Brinton, MD: Preventive Diabetes Measures


What are your thoughts on the current state of preventive diabetes measures?

Diabetes is a real scourge. It's a very common disorder, and it's becoming more common by the day. To me, one of the pieces we have not focused on adequately is the prevention of diabetes. I like to say that friends don't let friends get diabetes, so I'm really into the prevention of diabetes.

A major population of focus is the so-called "pre-diabetic," where the patient has metabolic syndrome and some resistance — the patient who is on his or her way to getting diabetes. I am very grateful that there's been increasing focus in the last many years on prevention of diabetes. We have several trials now that look at prevention of diabetes in the pre-diabetic patient. We have excellent evidence for diet and lifestyle. Even though we as clinicians tend to sometimes short-circuit that, if we're dealing with a patient who has insulin resistance, hypertriglyceridemia, metabolic syndrome, the odds that appropriate diet and exercise will help that patient are extremely high.

That doesn't make it easier for us to say, it doesn't make it easier for the patient to do, but to understand how useful it is I think is a huge step forward.

Related Videos
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
What Should the American Academy of Physician Associates Focus on in 2025?
GLP-1 Agonist Safety Risks and Obesity Stigma with Kevin Peterson, MD, MPH
Video 8 - "Pathophysiology of Hypercortisolism"
Video 7 - "Evolving Perception of Autonomous Adrenal Hypercortisolism "
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Daniel Gaudet, MD, PhD | Credit: American College of Cardiology
© 2024 MJH Life Sciences

All rights reserved.